Trial Profile
The comparison of effects of Filgrastim and Peg-Filgrastim in neutropenic patients
Status:
Active, no longer recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 16 Sep 2016
Price :
$35
*
At a glance
- Drugs Pegfilgrastim (Primary) ; Filgrastim
- Indications Neutropenia
- Focus Therapeutic Use
- Sponsors CinnaGen
- 24 Mar 2014 New trial record
- 01 Feb 2014 Recruitment complete